EPOC Epocrates, Inc. (MM)

Patient safety is a top priority for all clinicians, yet preventable drug errors are still prevalent throughout the United States. In the past year, Epocrates (Nasdaq:EPOC) has helped clinicians avoid more than 27 million adverse drug events through its popular medical application. This translates to more than 25 percent of Epocrates drug lookups preventing a minor to serious adverse drug event.

Sixty percent of U.S. physicians who use the Epocrates app reported avoiding at least one adverse drug error every week through the company's mobile and online reference products, according to a recent survey1. Physicians cite the drug Interaction Checker as the most helpful safety feature in the Epocrates app and a primary influence in changing prescribing decisions. The Interaction Checker enables clinicians to quickly enter up to 30 prescription, over-the-counter and alternative medicines to view potential interactions in order of severity. Additional safety features in the app include drug dosing, adverse reactions and news alerts.

"Epocrates delivers invaluable information at my fingertips with access to prescribing information when and where I need it," said Dr. W. Wolfe, Spotsylvania, Va. "The product has made my treatment of patients safer. I would find it more difficult to practice medicine without Epocrates, given the increasing complexities of medicine."

With drug information changing at a rapid pace, it is important for physicians to have information readily available at the point of care. In 2012, the Food and Drug Administration (FDA) approved 35 new prescription medications, one of the highest authorization levels in history. As more drugs join the market, new indications are approved and the average patient is taking multiple medications, physicians need easy access to trusted medication safety information instantly.

"Epocrates is a very valuable tool for me as someone with chronic illness on multiple medications. I need to closely monitor for potential interactions with my physician and can immediately review results together on a smartphone," said John Chaney, Pikeville, Ky.

The majority of U.S. physicians currently use a mobile device, such as a smartphone, tablet or combination of both, to access Epocrates. Most physicians who use the app access it daily, primarily during patient encounters. Epocrates products are available on popular platforms such as Apple iOS and Google Android OS. For more information and to download the app, visit www.epocrates.com/mobile.

About Epocrates, Inc.

Epocrates, Inc. (Nasdaq:EPOC) is recognized for developing the #1 medical application among U.S. physicians for clinical content, practice tools and health industry engagement at the point of care. Epocrates has established a loyal network of more than one million healthcare professionals, including 50 percent of U.S. physicians, who routinely use its intuitive solutions to help streamline workflow and improve patient care. The company also facilitates the delivery of valuable content and tools between partnering organizations and its members. For more information, please visit www.epocrates.com/company. 

The Epocrates, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=10943

Epocrates is a trademark of Epocrates, Inc., registered in the U.S. and other countries.

1 2012 Epocrates Specialty Survey (n= 2,700 U.S. physicians). Results are available at: http://www.epocrates.com/who/media/mediaresources/statistics.

CONTACT: Erica Sniad Morgenstern
         Senior Director, Public Relations and Communications
         Epocrates, Inc.
         (650) 227-6907
         pr@epocrates.com